Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth H Stover

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Nucleic Acids Research|April 23, 2025
DirectHRD enables sensitive scar-based classification of homologous recombination deficiencyRuolin Liu, Eugenia Roberts, Heather A Parsons, et al.
Blood|July 21, 2005
The small molecule tyrosine kinase inhibitor AMN107 inhibits TEL-PDGFRbeta and FIP1L1-PDGFRalpha in vitro and in vivoElizabeth H Stover, Jing Chen, Benjamin H Lee, et al.
Gynecologic Oncology|July 2, 2026
Toward precision prognosis: Predicting recurrence-free survival in high-grade serous ovarian cancer patients using multi-time point clinical and computed tomography radiomics dataLauren Roller, Ningxuan Zhou, Isha Atre, et al.
JCO Precision Oncology|December 7, 2023
Endometrial Cancer Risk Among Germline <i>BRCA1</i>/<i>2</i> Pathogenic Variant Carriers: Review of Our Current Understanding and Next StepsKimia Sorouri, Filipa Lynce, Colleen M Feltmate, et al.
Cell Stem Cell|June 6, 2009
Hedgehog signaling is dispensable for adult murine hematopoietic stem cell function and hematopoiesisInga Hofmann, Elizabeth H Stover, Dana E Cullen, et al.
JCO Precision Oncology|January 20, 2022
Clinical Pan-Cancer Assessment of Mismatch Repair Deficiency Using Tumor-Only, Targeted Next-Generation SequencingAdem Albayrak, Ana C Garrido-Castro, Marios Giannakis, et al.
Genome Medicine|May 21, 2021
Modeling clonal structure over narrow time frames via circulating tumor DNA in metastatic breast cancerZachary T Weber, Katharine A Collier, David Tallman, et al.
Cell Reports|December 13, 2018
PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian CancerLiya Ding, Hye-Jung Kim, Qiwei Wang, et al.
Gynecologic Oncology|August 11, 2020
Combined pembrolizumab and pegylated liposomal doxorubicin in platinum resistant ovarian cancer: A phase 2 clinical trialElizabeth K Lee, Niya Xiong, Su-Chun Cheng, et al.
Nature Communications|March 27, 2026
Mirvetuximab soravtansine plus pembrolizumab in recurrent folate receptor alpha-positive uterine serous carcinoma: a phase II trialRebecca L Porter, Yinglu Zhou, Nebiyat Eskndir, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Nucleic Acids Research|April 23, 2025
DirectHRD enables sensitive scar-based classification of homologous recombination deficiencyRuolin Liu, Eugenia Roberts, Heather A Parsons, et al.
Blood|July 21, 2005
The small molecule tyrosine kinase inhibitor AMN107 inhibits TEL-PDGFRbeta and FIP1L1-PDGFRalpha in vitro and in vivoElizabeth H Stover, Jing Chen, Benjamin H Lee, et al.
Gynecologic Oncology|July 2, 2026
Toward precision prognosis: Predicting recurrence-free survival in high-grade serous ovarian cancer patients using multi-time point clinical and computed tomography radiomics dataLauren Roller, Ningxuan Zhou, Isha Atre, et al.
JCO Precision Oncology|December 7, 2023
Endometrial Cancer Risk Among Germline <i>BRCA1</i>/<i>2</i> Pathogenic Variant Carriers: Review of Our Current Understanding and Next StepsKimia Sorouri, Filipa Lynce, Colleen M Feltmate, et al.
Cell Stem Cell|June 6, 2009
Hedgehog signaling is dispensable for adult murine hematopoietic stem cell function and hematopoiesisInga Hofmann, Elizabeth H Stover, Dana E Cullen, et al.
JCO Precision Oncology|January 20, 2022
Clinical Pan-Cancer Assessment of Mismatch Repair Deficiency Using Tumor-Only, Targeted Next-Generation SequencingAdem Albayrak, Ana C Garrido-Castro, Marios Giannakis, et al.
Genome Medicine|May 21, 2021
Modeling clonal structure over narrow time frames via circulating tumor DNA in metastatic breast cancerZachary T Weber, Katharine A Collier, David Tallman, et al.
Cell Reports|December 13, 2018
PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian CancerLiya Ding, Hye-Jung Kim, Qiwei Wang, et al.
Gynecologic Oncology|August 11, 2020
Combined pembrolizumab and pegylated liposomal doxorubicin in platinum resistant ovarian cancer: A phase 2 clinical trialElizabeth K Lee, Niya Xiong, Su-Chun Cheng, et al.
Nature Communications|March 27, 2026
Mirvetuximab soravtansine plus pembrolizumab in recurrent folate receptor alpha-positive uterine serous carcinoma: a phase II trialRebecca L Porter, Yinglu Zhou, Nebiyat Eskndir, et al.
Pageof 4